This macrophage, called MARCO+, was found to be elevated in people with the orphan disease, which affects around 70,000 Americans and currently has no effective treatment.
The research team injected mice with biodegradable PLG nanoparticles, short for poly (lactic-co-glycolic) acid.
The results, published in JCI Insight, reveal that PLG specifically targeted MARCO+ inflammatory cells and prevented skin and lung fibrosis.
Nanoparticle treatment could even reverse fibrosis in these mice, says John Varga, MD, senior author of the paper and chief of the Michigan Medicine Division of Rheumatology.
“The findings reveal a stark difference: untreated mice had terrible scarring in the lungs, and those treated with this nanoparticle saw the disease decease in severity or completely disappear“, said John Varga, MD, senior author of the paper and chief of the Michigan Medicine Division of Rheumatology.
“This is a promising step towards targeted treatment for patients with early scleroderma that could potentially mitigate the worst effects of the disease“.
The research team believes the MARCO+ cells become activated in people with scleroderma and circulate in the blood stream, traveling to the tissues and causing scar formation.
While the PLG nanoparticle reduced fibrosis in mouse models, Varga says future studies are needed to determine exactly how it prevents the MARCO+ activation.
PLG is already approved by the U.S. Food and Drug Administration for creating biodegradable sutures. In previous studies, Varga’s co-authors found that PLG decreased inflammation in mouse models of myocardial infarction. It is not currently available as a treatment for patients.
“We hope that this type of therapy will one day be evaluated in clinical trials for scleroderma“, Varga said. People with scleroderma are at great risk for skin and lung thickening that impacts function, and we look for any way to stop that from happening”.
Source: Medindia
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
